ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 217697 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 217697; 2) Community: the network communities that were significantly associated with the response to NSC 217697; 3) Molecule: the relationships between components within communities and NSC 217697; 4) MDR: the compounds that were significantly associated with the NSC 217697.

NSC Compound Enrichment Correlation
NSC 713326 Null 0.0208632511155816 0.47287765
NSC 720194 Null 0.0208632511155816 0.36813361
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0208632511155816 0.55497408
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.0208632511155816 0.39038031
NSC 748498 Null 0.0208632511155816 0.36689677
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0208632511155817 -0.0040686935
NSC 1906 1-Piperidinecarbodithioic acid, piperidine salt 0.0208632511155817 0.49085167
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0208632511155817 0.3611311
NSC 140380 Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) 0.0210461623330205 0.2481196
NSC 265211 NSC 265211 0.0210461623330207 0.26425651
Total:91  Current:47    [First] [Prev] [Next] [Last]